Grifols (GIFLF) Gross Margin Growth (3y) (2013 - 2024)
Powered by 
Analysis
Grifols (GIFLF) Gross Margin Growth (3y) (2013 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | -201.00 |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | 162.00 |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | -230.00 |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | -168.00 |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | -65.00 |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | 14,836.00 |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | 53.00 |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | -426.00 |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | -21.00 |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 6,385.00 |
| Dec 31, 2021 | -7,203.00 |
| Dec 31, 2020 | -8,232.00 |
| Mar 31, 2020 | -533.00 |
| Dec 31, 2019 | 2,060.00 |
| Mar 31, 2019 | -3,741.00 |
| Dec 31, 2018 | -216.00 |
| Jun 30, 2018 | -78.00 |
| Mar 31, 2018 | -188.00 |
| Dec 31, 2017 | 3,213.00 |
| Jun 30, 2017 | -64.00 |
| Mar 31, 2017 | -168.00 |
| Dec 31, 2016 | -214,942.00 |
| Sep 30, 2016 | -659.00 |
| Jun 30, 2016 | -396.00 |
| Mar 31, 2016 | 3,187.00 |
| Dec 31, 2015 | -192,003.00 |
| Sep 30, 2015 | -225.00 |
| Jun 30, 2015 | -356.00 |
| Mar 31, 2015 | -2.00 |